Achinghips
Well-Known Member
What's the difference please? From what I've read Danilon is kinder on the kidneys and more palatable. Anything else?
Can't even being to make a response like above, but - tried my old girl with Danilon, she refused to touch it and then refused to eat any hard food for 7 days after. Tried to syringe bute inwater into her - I wore most of it.
Finally had success (bute) with the ever reliable golden syrup sandwich!
Bute contains phenylbutazone. Danilon contains suxibuzone, which is metabolised by the horse's liver into (mostly) phenylbutazone. In the end up, an equivalent level of phenylbutazone is circulating in the bloodstream regardless of which product is used. This means that side effects on liver and kidney are identical between both products (no liver side effects, extremely uncommon kidney side effects).
There was a theory that as Danilon had already passed through the stomach before being activated into phenylbutazone, it would have fewer side effects in terms of gastric ulcers than bute. However, the mechanism of action of equine gastric damage with phenylbutazone involves the drug in the bloodstream, not in the stomach itself. This means that there will be no difference in ulcer formation between the two drugs. There was a published trial showing Danilon to be associated with less ulcer formation than phenylbutazone, but the trial used Danilon at a standard dose, and phenylbutazone at a double dose. The results are therefore pretty meaningless - the study has now been retracted, and Danilon cannot be legally advertised as safer for gastric health.
Neither bute nor danilon at commonly given doses cause gastric ulcers - this is a common misconception but there is absolutely no evidence that this is true.
The side effects of non-steroidal drugs (e.g. bute, Danilon, Finadyne, Metacam) are as follows:
Large colon ulceration (Right Dorsal Colitis) - uncommon at normal doses but does happen
Renal tubular damage - extremely uncommon
Caecal Impaction - incredibly uncommon
In short these are extremely safe and effective drugs when used at recommended doses. The only advantage of Danilon over bute is that it tastes nicer, and I would only recommend its use for a horse that refused to eat normal bute.
I just wanted to reply to say that my mare is currently recuperating from Right Dorsal Colitis, Caecal impaction, recurring colic and Gastric ulcers. She was on 4 Danilon a day for 3 days before she started going off her food, so a very very acute onslaught. So although uncommon, it does indeed happen. I am about 98% certain she didn't have the gastric ulcers before (and 100% sure there was no RDC/Impaction/Colic), but it is possible she got them via the starvation as a result of the colitis rather than directly from the Danilon - but it was related. She has wracked up over £5k in vets fees, spent 4 weeks in hospital, and is now on a no-hay, all soaked diet, meaning I am feeding her every 2 hours, plus getting up in the middle of the night.
My subsequent research since shows that the only reason to use bute/danilon is because it's cheap. The more modern NSAIDs don't target the Cox-1 receptors, and are therefore not only more targeted to the site of pain, but also far less likely to have gastric complications. I'll never use Bute/Danilon for short-term use on any of my horses ever again. We've considered having her PTS several times over the last few weeks. I'd go for Metacam or Equioxx (the newest, therefore most advanced) instead.
This explains the cox1-cox2.
http://www.equioxx.com/about.asp
I.e. there is no proven advantage of Equioxx over Bute. The same is true for Metacam. Drug companies are great at making claims without real evidence. Last time I spoke to a Boehringer-Ingelheim (make Metacam) rep, they harped on about how Metacam is better for laminitis because of its MMP inhibition, and cox-1 sparing properties. However, they could not provide evidence that outcomes for horses treated with Metacam are better than horses treated with Bute. There is a similar paucity of evidence showing less side effects with Metacam/Equioxx vs Danilon/Bute.* Clinical relevance has not been determined.